StreetAlpha.app
Home › Stocks › PRAX

Praxis Precision Medicines, Inc. (PRAX)

Healthcare
$305.06
▼ −1.68%
LAST CLOSE · NOV 17

Praxis Precision Medicines develops drugs for brain and nervous system disorders such as epilepsy and essential tremor. It last closed at $305.06 on Nov 17, down 1.68% on the day. The average 12-month price target from 9 analysts is $622.33 (+104.0% from the last close), with a high of $1050.00 and a low of $189.00. Analyst consensus is Buy, based on the latest ratings from 9 firms (8 buy, 0 hold, 1 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in PRAX, 100% of them bullish and 0% bearish. In the past 30 days there were 4 dark pool prints totaling $4.7M, the largest $1.5M.

AI Auto Pilots
Is PRAX in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Net income
−$359.4M
EPS (diluted)
−$12.82
Free cash flow
−$323.6M
Valuation
Market cap
$8.5B
28.0M shares
P/E
–
No P/E while losing money
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$361.9M
At Sep 30
Shareholder equity
$1.3B
Shares outstanding
28.0M
At Nov 4
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2022: $0$0FY2022FY2023: $2.4M$2.4MFY2023FY2024: $8.6M$8.6MFY2024FY2025: $0$0FY2025

From PRAX's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 9). Last 12 months adds up the four latest quarters.

Last report
Nov 9
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
Buy
Based on 9 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Buy
9firms
8 Buy0 Hold1 Sell
Each firm's latest rating on PRAX in the past 90 days
Average 12-month target
$622.33
▲ 104.0% upside

Based on 9 analysts who set a price target on PRAX in the past 90 days. The average target is $622.33, with a high of $1050.00 and a low of $189.00, compared with the last close of $305.06.

Low $189.00Avg $622.33High $1050.00
Blue marker: last close $305.06
Highest target$1050.00
Average target$622.33
Lowest target$189.00
Latest rating changes
Wells FargoUpgrade
Nov 17Buy$343 → $509
GuggenheimMaintained
Nov 16Buy$1050
BairdTarget raised
Nov 16Buy$400 → $568
RBC CapitalTarget raised
Nov 10Buy$462 → $478
WedbushTarget raised
Nov 10Sell$162 → $189
DateFirmActionRatingPrice target
Nov 17Wells FargoUpgradeBuy$343 → $509
Nov 16GuggenheimMaintainedBuy$1050
Nov 16BairdTarget raisedBuy$400 → $568
Nov 10RBC CapitalTarget raisedBuy$462 → $478
Nov 10WedbushTarget raisedSell$162 → $189
Loading…

Technical Analysis

PRAX · as of the Nov 17 close · updated after every close
Bounce inside a longer downtrend

The stock is 4% above its 20 day and 6% above its 50 day average. It is 3% below its 200 day average, so the longer trend is down. Momentum is improving (RSI 53). The nearest support is the swing low (Jul 17) at $299.16, and the nearest resistance the Pivot at $308.35.

Short trendBullish
Long trendBearish
MomentumImproving
StretchNormal
VolatilityHigh, 6.1%/day
Key levels
$392.7052 week high+28.7%
$325.66Swing high (Jul 20)+6.8%
$315.71Pivot R1+3.5%
$314.54200 day average+3.1%
$313.86100 day average+2.9%
$308.35Pivot+1.1%
$305.06Last close
$299.16Swing low (Jul 17)−1.9%
$297.70Pivot S1−2.4%
$291.3920 day average−4.5%
$288.1250 day average−5.6%
$160.1152 week low−47.5%
Indicators
RSI (14)53.08Middle of its rangeNeutral
MACD11.20Above its signal lineBullish
Stochastic59.0Middle of its rangeNeutral
ADX (14)22.6Weak trend
Williams %R-51.3Oversold below −80, overbought above −20Neutral
CCI (20)48.8Oversold below −100, overbought above 100Neutral
Rate of change+8.8%Change over 10 sessionsBullish
ATR (14)$18.55Typical daily range, 6.1% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Below
MA 200Below
What happened before, for PRAX

What happened before

See how PRAX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow PRAX usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How PRAX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
2
Bullish
2
100%
Bearish
0
0%
Date span
Sep 30 – Oct 7
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
4
Notional
$4.7M
Largest print
$1.5M
Loading…

PRAX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲203 buying vs 137 selling
  • ▲Held by funds +3.2 pts
  • ▲Funds holding +23
  • ▲Superinvestors: 2 added, 0 cut
  • ▲Put/call 15.22 to 1.62
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding337314+7.3%
In funds' top 101518−16.7%
Held by funds123.9%120.7%+3.2 pts
New / increased72 / 13160 / 122+11.5%
Reduced / sold out92 / 4595 / 39+2.2%
Put/call ratio1.6215.22−89.4%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See PRAX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PRAX is in one of them and how their past PRAX trades turned out.

PRAX in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered PRAX in an article yet. Here's the latest on the wider market.

PRAX Congress Trades

All congress trades →
Trades, 12 months
2
Buys
2
100%
Sells
0
0%
People
1
Last filed Oct 12
Who traded PRAX · since 2026
Latest 2 filings
$1K – $15KTraded Sep 29, 2026Filed Oct 12, 2026
$1K – $15KTraded Jul 30, 2026Filed Sep 4, 2026
PersonTypeAmountTradedFiledDelay
Gilbert CisnerosD · CABuy$1K – $15KSep 29, 2026Oct 12, 202613 d
Gilbert CisnerosD · CABuy$1K – $15KJul 30, 2026Sep 4, 202636 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Praxis Precision Medicines

Praxis Precision Medicines is a biopharmaceutical company based in Boston, Massachusetts. It develops treatments for brain and nervous system disorders, using genetic research on epilepsy as a starting point. Its two platforms create small molecule therapies taken by mouth and antisense oligonucleotide drugs. Its most advanced candidate targets essential tremor, and its other candidates address movement disorders and epilepsy in patients.

Headquarters
Boston, MA